ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 72 filers reported holding ESSA PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,358 | -0.0% | 21,475 | -12.6% | 0.00% | – |
| Q2 2023 | $66,374 | -64.8% | 24,583 | -61.2% | 0.00% | – |
| Q1 2023 | $188,298 | +13.9% | 63,400 | -3.4% | 0.00% | – |
| Q4 2022 | $165,312 | +132.8% | 65,600 | +68.2% | 0.00% | – |
| Q3 2022 | $71,000 | +31.5% | 39,000 | +128.1% | 0.00% | – |
| Q2 2022 | $54,000 | -59.4% | 17,100 | -20.8% | 0.00% | – |
| Q1 2022 | $133,000 | -98.1% | 21,600 | -95.6% | 0.00% | -100.0% |
| Q4 2021 | $7,034,000 | +28.2% | 495,297 | -27.7% | 0.00% | 0.0% |
| Q3 2021 | $5,485,000 | -73.4% | 685,531 | -4.9% | 0.00% | -80.0% |
| Q2 2021 | $20,590,000 | +45.6% | 720,701 | +48.1% | 0.01% | +66.7% |
| Q1 2021 | $14,137,000 | +195.1% | 486,659 | +21.2% | 0.00% | +200.0% |
| Q4 2020 | $4,791,000 | +72.6% | 401,612 | -0.2% | 0.00% | 0.0% |
| Q3 2020 | $2,776,000 | – | 402,344 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 1,826,980 | $12,606,000 | 6.68% |
| Omega Fund Management, LLC | 912,693 | $6,096,000 | 1.65% |
| BVF INC/IL | 3,005,589 | $20,739,000 | 1.13% |
| Sio Capital Management, LLC | 656,043 | $4,527,000 | 0.90% |
| Avidity Partners Management LP | 2,087,800 | $14,406,000 | 0.67% |
| Vivo Capital, LLC | 1,516,865 | $10,466,000 | 0.60% |
| Opaleye Management Inc. | 271,350 | $1,872,000 | 0.37% |
| Eventide Asset Management | 2,335,169 | $15,307,000 | 0.30% |
| CAXTON CORP | 26,590 | $183,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 250,000 | $1,725,000 | 0.17% |